默克制药：公司预计，美国总统特朗普15%医药关税在2025年造成的“影响偏低”。

Core Viewpoint - The company expects that the impact of the 15% pharmaceutical tariff proposed by President Trump in 2025 will be "relatively low" [1] Company Summary - The company, Merck, is assessing the potential effects of the upcoming tariff on its operations and financial performance [1]